STEEL DYNAMICS INC

STLD

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: Immaterial for Biotech Thesis** Eventide's $583K position in Steel Dynamics (STLD) signals a notable pivot away from pure-play biotech allocation toward industrial materials/steel.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 3,411Value: $583K

**Signal Note: Immaterial for Biotech Thesis** Eventide's $583K position in Steel Dynamics (STLD) signals a notable pivot away from pure-play biotech allocation toward industrial materials/steel. This contradicts the fund's stated "strong biotech allocation" positioning and suggests either portfolio rebalancing, ESG-driven infrastructure thesis, or cash deployment into non-healthcare sectors. No clinical catalysts or drug-specific developments are relevant to this equity purchase.

More STLD Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: